• Je něco špatně v tomto záznamu ?

Implications of flavonoids as potential modulators of cancer neovascularity

A. Liskova, L. Koklesova, M. Samec, E. Varghese, M. Abotaleb, SM. Samuel, K. Smejkal, K. Biringer, M. Petras, D. Blahutova, O. Bugos, M. Pec, M. Adamkov, D. Büsselberg, R. Ciccocioppo, M. Adamek, L. Rodrigo, M. Caprnda, P. Kruzliak, P. Kubatka,

. 2020 ; 146 (12) : 3079-3096. [pub] 20200909

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20027609

Grantová podpora
VEGA 1/0136/19 Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR

PURPOSE: The formation of new blood vessels from previous ones, angiogenesis, is critical in tissue repair, expansion or remodeling in physiological processes and in various pathologies including cancer. Despite that, the development of anti-angiogenic drugs has great potential as the treatment of cancer faces many problems such as development of the resistance to treatment or an improperly selected therapy approach. An evaluation of predictive markers in personalized medicine could significantly improve treatment outcomes in many patients. METHODS: This comprehensive review emphasizes the anticancer potential of flavonoids mediated by their anti-angiogenic efficacy evaluated in current preclinical and clinical cancer research. RESULTS AND CONCLUSION: Flavonoids are important groups of phytochemicals present in common diet. Flavonoids show significant anticancer effects. The anti-angiogenic effects of flavonoids are currently a widely discussed topic of preclinical cancer research. Flavonoids are able to regulate the process of tumor angiogenesis through modulation of signaling molecules such as VEGF, MMPs, ILs, HIF or others. However, the evaluation of the anti-angiogenic potential of flavonoids within the clinical studies is not frequently discussed and is still of significant scientific interest.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027609
003      
CZ-PrNML
005      
20210114152130.0
007      
ta
008      
210105s2020 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00432-020-03383-8 $2 doi
035    __
$a (PubMed)32902794
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Liskova, Alena $u Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.
245    10
$a Implications of flavonoids as potential modulators of cancer neovascularity / $c A. Liskova, L. Koklesova, M. Samec, E. Varghese, M. Abotaleb, SM. Samuel, K. Smejkal, K. Biringer, M. Petras, D. Blahutova, O. Bugos, M. Pec, M. Adamkov, D. Büsselberg, R. Ciccocioppo, M. Adamek, L. Rodrigo, M. Caprnda, P. Kruzliak, P. Kubatka,
520    9_
$a PURPOSE: The formation of new blood vessels from previous ones, angiogenesis, is critical in tissue repair, expansion or remodeling in physiological processes and in various pathologies including cancer. Despite that, the development of anti-angiogenic drugs has great potential as the treatment of cancer faces many problems such as development of the resistance to treatment or an improperly selected therapy approach. An evaluation of predictive markers in personalized medicine could significantly improve treatment outcomes in many patients. METHODS: This comprehensive review emphasizes the anticancer potential of flavonoids mediated by their anti-angiogenic efficacy evaluated in current preclinical and clinical cancer research. RESULTS AND CONCLUSION: Flavonoids are important groups of phytochemicals present in common diet. Flavonoids show significant anticancer effects. The anti-angiogenic effects of flavonoids are currently a widely discussed topic of preclinical cancer research. Flavonoids are able to regulate the process of tumor angiogenesis through modulation of signaling molecules such as VEGF, MMPs, ILs, HIF or others. However, the evaluation of the anti-angiogenic potential of flavonoids within the clinical studies is not frequently discussed and is still of significant scientific interest.
650    _2
$a inhibitory angiogeneze $x terapeutické užití $7 D020533
650    _2
$a flavonoidy $x terapeutické užití $7 D005419
650    _2
$a lidé $7 D006801
650    _2
$a interleukiny $x genetika $7 D007378
650    _2
$a matrixové metaloproteinasy $x genetika $7 D020782
650    _2
$a nádory $x farmakoterapie $x genetika $x patologie $7 D009369
650    _2
$a patologická angiogeneze $x farmakoterapie $x genetika $x patologie $7 D009389
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a vaskulární endoteliální růstový faktor A $x genetika $7 D042461
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Koklesova, Lenka $u Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.
700    1_
$a Samec, Marek $u Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.
700    1_
$a Varghese, Elizabeth $u Department of Physiology and Biophysics, Weill Cornell Medicine in Qatar, Education City, Qatar Foundation, Doha, 24144, Qatar.
700    1_
$a Abotaleb, Mariam $u Department of Physiology and Biophysics, Weill Cornell Medicine in Qatar, Education City, Qatar Foundation, Doha, 24144, Qatar.
700    1_
$a Samuel, Samson Mathews $u Department of Physiology and Biophysics, Weill Cornell Medicine in Qatar, Education City, Qatar Foundation, Doha, 24144, Qatar.
700    1_
$a Smejkal, Karel $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.
700    1_
$a Biringer, Kamil $u Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.
700    1_
$a Petras, Martin $u Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
700    1_
$a Blahutova, Dana $u Department of Biology and Ecology, Faculty of Education, Catholic University in Ruzomberok, Ruzomberok, Slovakia.
700    1_
$a Bugos, Ondrej $u Lambda Life JSC., Bratislava, Slovakia.
700    1_
$a Pec, Martin $u Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01, Martin, Slovakia.
700    1_
$a Adamkov, Marian $u Department of Histology and Embryology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
700    1_
$a Büsselberg, Dietrich $u Department of Physiology and Biophysics, Weill Cornell Medicine in Qatar, Education City, Qatar Foundation, Doha, 24144, Qatar. dib2015@qatar-med.cornell.edu.
700    1_
$a Ciccocioppo, Rachele $u Gastroenterology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata Policlinico GB Rossi, University of Verona, Verona, Italy.
700    1_
$a Adamek, Mariusz $u Department of Thoracic Surgery, Faculty of Medicine and Dentistry, Medical University of Silesia, Katowice, Poland.
700    1_
$a Rodrigo, Luis $u Faculty of Medicine, University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
700    1_
$a Caprnda, Martin $u 1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
700    1_
$a Kruzliak, Peter $u 2nd Department of Surgery, Faculty of Medicine, Masaryk University, Pekarska 53, 656 91, Brno, Czech Republic. kruzliakpeter@gmail.com. St. Anne's University Hospital, Brno, Czech Republic. kruzliakpeter@gmail.com.
700    1_
$a Kubatka, Peter $u Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01, Martin, Slovakia. peter.kubatka@uniba.sk.
773    0_
$w MED00009972 $t Journal of cancer research and clinical oncology $x 1432-1335 $g Roč. 146, č. 12 (2020), s. 3079-3096
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32902794 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152128 $b ABA008
999    __
$a ok $b bmc $g 1607944 $s 1118789
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 146 $c 12 $d 3079-3096 $e 20200909 $i 1432-1335 $m Journal of cancer research and clinical oncology $n J Cancer Res Clin Oncol $x MED00009972
GRA    __
$a VEGA 1/0136/19 $p Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace